Developer docs
API playgroundTry for free, no card

Search company profiles

Futurity Bio-Ventures

Full company profile

uuid0006mda

Namestring
Futurity Bio-Ventures
Legal namestring
Futurity Group Limited
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Futurity Bio-Ventures (legally Futurity Group Limited, New Zealand company #6824594) is a private, Gisborne-based renewable chemicals company founded in 2017 that converts lignin from New Zealand P. radiata plantation forestry and pulp-and-paper by-products into petrochemical-replacement intermediates. Its technology platform centres on the METNIN® enzymatic fractionation process licensed from Finland's MetGen Oy in 2022, combined with in-house proprietary lignin formulations marketed under the LIGNO™ and LIMA™ trade names. The LIGNO™ family spans LIGNO™ 100 (intermediate-molecular-weight lignin), lignin-based phenolics for adhesives and wood products (LVL, MDF, plywood), lignin-based polyols for polyurethane foams, and UV adsorbent additives for textiles and cosmetics; LIMA™ and LIMA™ Plus are lignin-based asphalt binder additives that can substitute up to 30% of bitumen. METNIN® SHIELD is a validated paper additive that delivers a 33% compression-strength increase and 70% reduction in Cobb values, with FDA/EU food-contact and re-pulpability certifications.

The company operates a direct, enterprise-focused B2B sales motion targeting industrial buyers across construction and infrastructure, packaging, cosmetics and textiles, and pulp and paper. Distribution relies on field sales, sample-based technical engagement, and licence-driven commercial arrangements, with no published pricing and all commercial enquiries funnelled through website forms or direct email. Revenue-generating streams include proprietary product sales of LIGNO™ grades and LIMA™ additives, supplemented by potential licensing and operating income from METNIN®-enabled lignin-centric biorefineries.

Futurity is pre-commercial at scale, with a team of fewer than 10 staff focused on R&D and pilot activity. Total disclosed funding to date is approximately NZ$274,000 in non-dilutive grants (Callaghan Innovation and an MBIE PreSeed Accelerator Fund award, the latter co-funded with Scion Research and Trust Tairāwhiti). Four large-scale trials have been completed using local feedstock and global partners, and the company is working toward the first advanced biorefinery in Australasia, planned for the Tairāwhiti Gisborne region. The firm is advised by Dr. Sean Simpson, founder of LanzaTech and LanzaJet (LanzaJet valued above US$1 billion), signaling credible clean-tech commercialisation expertise backing the scaling plan.

Short descriptiontext

Futurity Bio-Ventures is a New Zealand private company that develops lignin-based renewable chemicals and materials from plantation forestry by-products, selling proprietary LIGNO™ and LIMA™ products to enterprise customers in construction, infrastructure, packaging, cosmetics, and textiles via direct B2B sales.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersWainui, New Zealand
HQ citystring
Wainui
HQ countrystring
New Zealand
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
lignin-based chemicals, renewable materials, bio-based additives, forestry by-products, sustainable petrochemical alternatives
Industry7 codes
PRIMARYIMAMALAB
Biochemicals & Bio-based Platform Chemicals (cellulose sugars, lignin derivatives, organic acids)
SECONDARYIMAMALAE
Lignin-based Materials & Carbon Products (binders, resins, carbon fiber/activated carbon)
SECONDARYIMAMALAG
Bio-based Adhesives, Coatings & Sealants (lignin/tannin/soy-based)
SECONDARYEUAAAIAG
Bio-based Resins, Adhesives, Coatings & Sealants
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYIMAMALAC
Bio-based Polymers & Resins (PLA, PHA, bio-PE, bio-PET, cellulose acetate)
SECONDARYIMAMALAL
Biorefinery Technology & Contract Processing (fractionation, tolling, scale-up)
SECONDARYEUAAAIAD
Bio-based Materials & Fibers (e.g., cellulose derivatives, lignin-based materials, nanocellulose)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
NAICS code3 codes
  • Cyclic Crude, Intermediate, and Gum and Wood Chemical Manufacturing325194
  • Plastics Material and Resin Manufacturing325211
  • Chemical Manufacturing325
SIC code2 codes
  • Industrial Organic Chemicals2860
  • Miscellaneous Chemical Products2890
Product category
Renewable Chemicals & Bio-based Materials
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Renewable Chemical Products Sales
TypeOne Time License
Description

Futurity generates revenue through the sale of proprietary lignin-based products including LIGNO™ grades (LIGNO™ 100) and LIMA™ asphalt additives. Products target industrial customers in construction, infrastructure, packaging, cosmetics, and textiles markets.

futuritybioventures.com
2Technology Licensing
TypeLicensing Royalties
Description

Through the METNIN® technology license agreement with MetGen Oy, Futurity can build and operate lignin-centric biorefineries in New Zealand, potentially generating licensing and operational revenue from biorefinery operations.

futuritybioventures.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure
Pricing details1 tier
1B2B direct engagement for product samples and commercial orders
ModelOther
Notes

Request a Sample and Make an Enquiry options available on website for custom product discussions. No published pricing tiers.

futuritybioventures.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1LIGNO™
Description

Trade name for a range of lignin grades produced from waste wood sourced from New Zealand's plantation forestry and pulp/paper by-products. Includes LIGNO™ 100 (intermediate molecular weight) for phenolics, polyurethanes, and UV additives.

futuritybioventures.com
+2 more records
Core offering1 text field

Futurity Bio-Ventures develops and sells a portfolio of lignin-based renewable chemicals and materials derived from New Zealand plantation forestry and pulp/paper by-products. The company's product range includes LIGNO™ lignin grades (LIGNO™ 100, Phenolics, Polyurethanes, UV Additives), LIMA™ asphalt binder additives (including LIMA™ Plus), and METNIN™ SHIELD paper additive, sold to industrial customers in construction, infrastructure, packaging, cosmetics, and textiles as alternatives to fossil-based petrochemicals.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • UPF improvements of over 700%, reaching UPF factors of 50+ on treated textiles
+4 more records
Product overview1 text field

Futurity Bio-Ventures offers a portfolio of lignin-based renewable chemical products centered on LIGNO™ (lignin grades) and LIMA™ (asphalt binder additives). LIGNO™ encompasses sub-products including LIGNO™ 100, Phenolics, Polyurethanes, and UV Additives targeting applications in wood products, foams, adhesives, coatings, textiles, cosmetics, and electronics. LIMA™ products (including LIMA™ Plus) serve the asphalt surfacing market. METNIN™ SHIELD addresses paper/packaging applications. The company operates as a unified platform developing renewable materials from specialty cellulose, hemicellulose, and lignin sourced from New Zealand plantation forestry.

Product and service1 record
1LIGNO™ 100
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-10-03
Description

MetGen Oy (Finland) is a world-leading supplier of commercial enzymes and associated enzyme-based processes. Futurity signed a technology license agreement enabling them to build and operate lignin-centric biorefineries using METNIN® Technologies in New Zealand. The collaboration aims for products that are better and more affordable than fossil-based alternatives.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

New Zealand's innovation agency providing grant funding and R&D support. Presented Futurity in the Business is Boring podcast association. Works with innovators and entrepreneurs to accelerate commercialisation.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Crown Research Institute focused on forestry and forestry products. Natural alignment with Futurity with shared ambition to establish advanced Biorefining for New Zealand. Co-funded the MBIE PSAF project with FBV and Trust Tairāwhiti.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

New Zealand Government entity providing support to align investors throughout development stages. Provides assistance with intellectual property development and engineering evaluation through targeted grants.

5Dr. Sean Simpson
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Advisory board member. Founder of LanzaTech and LanzaJet (valued at over US$1b). Provides expertise in startup, scale-up, and commercial development of clean-tech ventures with over 10 years of experience.

futuritybioventures.com
6Matanuku Mahuika
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Advisory board member with significant governance experience. Currently chair of Eastland Generation (renewable energy developer jointly owned with Obayashi Corporation). Experience spans fisheries, agribusiness, investment, infrastructure and Māori economic development.

futuritybioventures.com
7Richard Mehrtens
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Advisory board member and Managing Director of GLOBALEAGLE. Over 35 years of experience in legal, investment banking, strategy/structuring, and governance roles. Ex-partner of Russell McVeagh, chairman of AJ Hackett Bungy NZ.

futuritybioventures.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Domtar is a major North American pulp and paper company that produces BioChoice™ lignin from its Plymouth NC biorefinery. It sells lignin into agricultural, industrial, and specialty applications and represents an established commercial-scale lignin supplier in the same product category as Futurity.

TypeBroad incumbent
Description

Borregaard is the world's leading commercial producer of lignin-based products (lignosulfonates and specialty lignins), operating the Sarpsborg biorefinery in Norway. It sells bio-based specialty chemicals into construction, agriculture, and industrial applications - the same end-markets Futurity targets - but at much larger scale and with an established global customer base.

TypeBroad incumbent
Description

Stora Enso is one of the largest private forest owners globally and produces lignin (Lineo®) from its Sunila mill in Finland for use as a phenol replacement in phenolic resins and foams. Stora Enso's Lineo lignin competes head-to-head with Futurity's LIGNO™ 100 phenolics application.

TypeBroad incumbent
Description

UPM Biochemicals produces renewable mono-propylene glycol, lignin-based renewable fillers, and biochemicals from forest biomass at commercial scale in Finland and Germany. It is a major forest-industry incumbent developing lignin applications for resins, coatings, and plastics - directly overlapping with Futurity's LIGNO™ phenolics and polyurethanes roadmap.

TypeEmerging player
Description

Renmatix is a US-based technology company that converts plant-based biomass into sustainable chemical building blocks using supercritical hydrolysis. It targets renewable chemicals and materials from non-food biomass, overlapping with Futurity's mission of replacing fossil-derived inputs with renewable alternatives.

TypeEmerging player
Description

Bloom Biorenewables is a Switzerland-based startup developing bio-based polymers and materials from lignocellulosic biomass, including alternatives to phenol-formaldehyde resins and high-performance aromatic polymers. It targets similar end-applications (adhesives, foams, coatings) and is at a comparable early-commercial stage to Futurity.

TypeDirect peer
Description

MetGen is a Finland-based industrial biotechnology company developing enzyme-based processes including the METNIN® enzymatic lignin fractionation technology that Futurity licenses. It is the direct upstream technology peer and partner; its METNIN platform produces differentiated lignin grades for the same end-applications Futurity targets.

TypeBroad incumbent
Description

Suzano is the world's largest eucalyptus pulp producer and is actively developing lignin-based products (Eucalig™) from its Brazilian operations for use in phenolic resins, foams, and biopolymers. It is a global forest-products incumbent with deep R&D capability directly comparable to Futurity's LIGNO™ platform.

TypeEmerging player
Description

Anomera is a Canadian biomaterials company producing cellulose nanocrystals (CNC) from forest biomass for cosmetics, electronics, and industrial applications. It shares Futurity's model of converting forestry by-products into high-value specialty materials, though using a different (cellulosic) fraction of the biomass.

TypeOthers
Description

LanzaTech is a US-based clean-tech company using gas-fermentation to convert industrial off-gases into ethanol and chemical building blocks. It is not a direct lignin competitor but is thematically related as a renewable-chemicals platform and has direct governance overlap with Futurity through advisory board member Dr. Sean Simpson.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Futurity Bio-Ventures

Renewable Chemicals & Bio-based Materialsfuturitybioventures.com

Futurity Bio-Ventures is a New Zealand private company that develops lignin-based renewable chemicals and materials from plantation forestry by-products, selling proprietary LIGNO™ and LIMA™ products to enterprise customers in construction, infrastructure, packaging, cosmetics, and textiles via direct B2B sales.

What Futurity Bio-Ventures does

Futurity Bio-Ventures (legally Futurity Group Limited, New Zealand company #6824594) is a private, Gisborne-based renewable chemicals company founded in 2017 that converts lignin from New Zealand P. radiata plantation forestry and pulp-and-paper by-products into petrochemical-replacement intermediates. Its technology platform centres on the METNIN® enzymatic fractionation process licensed from Finland's MetGen Oy in 2022, combined with in-house proprietary lignin formulations marketed under the LIGNO™ and LIMA™ trade names. The LIGNO™ family spans LIGNO™ 100 (intermediate-molecular-weight lignin), lignin-based phenolics for adhesives and wood products (LVL, MDF, plywood), lignin-based polyols for polyurethane foams, and UV adsorbent additives for textiles and cosmetics; LIMA™ and LIMA™ Plus are lignin-based asphalt binder additives that can substitute up to 30% of bitumen. METNIN® SHIELD is a validated paper additive that delivers a 33% compression-strength increase and 70% reduction in Cobb values, with FDA/EU food-contact and re-pulpability certifications.

The company operates a direct, enterprise-focused B2B sales motion targeting industrial buyers across construction and infrastructure, packaging, cosmetics and textiles, and pulp and paper. Distribution relies on field sales, sample-based technical engagement, and licence-driven commercial arrangements, with no published pricing and all commercial enquiries funnelled through website forms or direct email. Revenue-generating streams include proprietary product sales of LIGNO™ grades and LIMA™ additives, supplemented by potential licensing and operating income from METNIN®-enabled lignin-centric biorefineries.

Futurity is pre-commercial at scale, with a team of fewer than 10 staff focused on R&D and pilot activity. Total disclosed funding to date is approximately NZ$274,000 in non-dilutive grants (Callaghan Innovation and an MBIE PreSeed Accelerator Fund award, the latter co-funded with Scion Research and Trust Tairāwhiti). Four large-scale trials have been completed using local feedstock and global partners, and the company is working toward the first advanced biorefinery in Australasia, planned for the Tairāwhiti Gisborne region. The firm is advised by Dr. Sean Simpson, founder of LanzaTech and LanzaJet (LanzaJet valued above US$1 billion), signaling credible clean-tech commercialisation expertise backing the scaling plan.

Futurity Bio-Ventures firmographics

Firmographics
Name
Futurity Bio-Ventures
Legal name
Futurity Group Limited
Website
https://futuritybioventures.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
1–10 employees
Short description
Futurity Bio-Ventures is a New Zealand private company that develops lignin-based renewable chemicals and materials from plantation forestry by-products, selling proprietary LIGNO™ and LIMA™ products to enterprise customers in construction, infrastructure, packaging, cosmetics, and textiles via direct B2B sales.
Ownership category
akta.pro rank

Futurity Bio-Ventures industry classification

Industry
Product category
Renewable Chemicals & Bio-based Materials
NAICS
Cyclic Crude, Intermediate, and Gum and Wood Chemical Manufacturing (325194), Plastics Material and Resin Manufacturing (325211), Chemical Manufacturing (325)
SIC
Industrial Organic Chemicals (2860), Miscellaneous Chemical Products (2890)
akta.pro industry
PRIMARYIMAMALAB
Biochemicals & Bio-based Platform Chemicals (cellulose sugars, lignin derivatives, organic acids)
SECONDARYIMAMALAE
Lignin-based Materials & Carbon Products (binders, resins, carbon fiber/activated carbon)
SECONDARYIMAMALAG
Bio-based Adhesives, Coatings & Sealants (lignin/tannin/soy-based)
SECONDARYEUAAAIAG
Bio-based Resins, Adhesives, Coatings & Sealants
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYIMAMALAC
Bio-based Polymers & Resins (PLA, PHA, bio-PE, bio-PET, cellulose acetate)
SECONDARYIMAMALAL
Biorefinery Technology & Contract Processing (fractionation, tolling, scale-up)
SECONDARYEUAAAIAD
Bio-based Materials & Fibers (e.g., cellulose derivatives, lignin-based materials, nanocellulose)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)

Keywords

  • Lignin-based chemicals
  • Renewable materials
  • Bio-based additives
  • Forestry by-products
  • Sustainable petrochemical alternatives

Where Futurity Bio-Ventures is headquartered

Location

Headquarters

HQ city
Wainui
HQ country
New Zealand
HQ region
Oceania

Offices1 record

Markets served

Futurity Bio-Ventures business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Renewable Chemical Products Sales: Futurity generates revenue through the sale of proprietary lignin-based products including LIGNO™ grades (LIGNO™ 100) and LIMA™ asphalt additives. Products target industrial customers in construction, infrastructure, packaging, cosmetics, and textiles markets.
  2. Technology Licensing: Through the METNIN® technology license agreement with MetGen Oy, Futurity can build and operate lignin-centric biorefineries in New Zealand, potentially generating licensing and operational revenue from biorefinery operations.

Pricing tiers

ModelBillingPrice
Other—B2B direct engagement for product samples and commercial orders

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Futurity Bio-Ventures product offering

Product offering

Core offering

Futurity Bio-Ventures develops and sells a portfolio of lignin-based renewable chemicals and materials derived from New Zealand plantation forestry and pulp/paper by-products. The company's product range includes LIGNO™ lignin grades (LIGNO™ 100, Phenolics, Polyurethanes, UV Additives), LIMA™ asphalt binder additives (including LIMA™ Plus), and METNIN™ SHIELD paper additive, sold to industrial customers in construction, infrastructure, packaging, cosmetics, and textiles as alternatives to fossil-based petrochemicals.

Product overview

Futurity Bio-Ventures offers a portfolio of lignin-based renewable chemical products centered on LIGNO™ (lignin grades) and LIMA™ (asphalt binder additives). LIGNO™ encompasses sub-products including LIGNO™ 100, Phenolics, Polyurethanes, and UV Additives targeting applications in wood products, foams, adhesives, coatings, textiles, cosmetics, and electronics. LIMA™ products (including LIMA™ Plus) serve the asphalt surfacing market. METNIN™ SHIELD addresses paper/packaging applications. The company operates as a unified platform developing renewable materials from specialty cellulose, hemicellulose, and lignin sourced from New Zealand plantation forestry.

Differentiator

Problem solved

Functional benefit

Brands

  • LIGNO™: Trade name for a range of lignin grades produced from waste wood sourced from New Zealand's plantation forestry and pulp/paper by-products. Includes LIGNO™ 100 (intermediate molecular weight) for phenolics, polyurethanes, and UV additives.
  • LIMA™
  • METNIN® SHIELD

Products and services

  • LIGNO™ 100

Quantifiable outcome

  • UPF improvements of over 700%, reaching UPF factors of 50+ on treated textiles
  • +4 more outcomes

Companies that use Futurity Bio-Ventures

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Futurity Bio-Ventures technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Futurity Bio-Ventures partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • MetGen OycoreTechnology or Integration · 3 October 2022MetGen Oy (Finland) is a world-leading supplier of commercial enzymes and associated enzyme-based processes. Futurity signed a technology license agreement enabling them to build and operate lignin-centric biorefineries using METNIN® Technologies in New Zealand. The collaboration aims for products that are better and more affordable than fossil-based alternatives.
  • Callaghan InnovationcoreStrategic or Co-development PartnerNew Zealand's innovation agency providing grant funding and R&D support. Presented Futurity in the Business is Boring podcast association. Works with innovators and entrepreneurs to accelerate commercialisation.
  • Scion ResearchcoreStrategic or Co-development PartnerCrown Research Institute focused on forestry and forestry products. Natural alignment with Futurity with shared ambition to establish advanced Biorefining for New Zealand. Co-funded the MBIE PSAF project with FBV and Trust Tairāwhiti.
  • NZTE (New Zealand Trade & Enterprise)coreStrategic or Co-development PartnerNew Zealand Government entity providing support to align investors throughout development stages. Provides assistance with intellectual property development and engineering evaluation through targeted grants.
  • Dr. Sean SimpsoncoreStrategic or Co-development PartnerAdvisory board member. Founder of LanzaTech and LanzaJet (valued at over US$1b). Provides expertise in startup, scale-up, and commercial development of clean-tech ventures with over 10 years of experience.
  • Matanuku MahuikacoreStrategic or Co-development PartnerAdvisory board member with significant governance experience. Currently chair of Eastland Generation (renewable energy developer jointly owned with Obayashi Corporation). Experience spans fisheries, agribusiness, investment, infrastructure and Māori economic development.
  • Richard MehrtensminorStrategic or Co-development PartnerAdvisory board member and Managing Director of GLOBALEAGLE. Over 35 years of experience in legal, investment banking, strategy/structuring, and governance roles. Ex-partner of Russell McVeagh, chairman of AJ Hackett Bungy NZ.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Futurity Bio-Ventures competitors and assessment

Company assessment

Broad incumbents

  • Domtar (BioChoice): Domtar is a major North American pulp and paper company that produces BioChoice™ lignin from its Plymouth NC biorefinery. It sells lignin into agricultural, industrial, and specialty applications and represents an established commercial-scale lignin supplier in the same product category as Futurity.
  • Borregaard: Borregaard is the world's leading commercial producer of lignin-based products (lignosulfonates and specialty lignins), operating the Sarpsborg biorefinery in Norway. It sells bio-based specialty chemicals into construction, agriculture, and industrial applications - the same end-markets Futurity targets - but at much larger scale and with an established global customer base.
  • Stora Enso: Stora Enso is one of the largest private forest owners globally and produces lignin (Lineo®) from its Sunila mill in Finland for use as a phenol replacement in phenolic resins and foams. Stora Enso's Lineo lignin competes head-to-head with Futurity's LIGNO™ 100 phenolics application.
  • UPM Biochemicals: UPM Biochemicals produces renewable mono-propylene glycol, lignin-based renewable fillers, and biochemicals from forest biomass at commercial scale in Finland and Germany. It is a major forest-industry incumbent developing lignin applications for resins, coatings, and plastics - directly overlapping with Futurity's LIGNO™ phenolics and polyurethanes roadmap.
  • Suzano: Suzano is the world's largest eucalyptus pulp producer and is actively developing lignin-based products (Eucalig™) from its Brazilian operations for use in phenolic resins, foams, and biopolymers. It is a global forest-products incumbent with deep R&D capability directly comparable to Futurity's LIGNO™ platform.

Emerging players

  • Renmatix: Renmatix is a US-based technology company that converts plant-based biomass into sustainable chemical building blocks using supercritical hydrolysis. It targets renewable chemicals and materials from non-food biomass, overlapping with Futurity's mission of replacing fossil-derived inputs with renewable alternatives.
  • Bloom Biorenewables: Bloom Biorenewables is a Switzerland-based startup developing bio-based polymers and materials from lignocellulosic biomass, including alternatives to phenol-formaldehyde resins and high-performance aromatic polymers. It targets similar end-applications (adhesives, foams, coatings) and is at a comparable early-commercial stage to Futurity.
  • Anomera: Anomera is a Canadian biomaterials company producing cellulose nanocrystals (CNC) from forest biomass for cosmetics, electronics, and industrial applications. It shares Futurity's model of converting forestry by-products into high-value specialty materials, though using a different (cellulosic) fraction of the biomass.

Direct peers

  • MetGen Oy: MetGen is a Finland-based industrial biotechnology company developing enzyme-based processes including the METNIN® enzymatic lignin fractionation technology that Futurity licenses. It is the direct upstream technology peer and partner; its METNIN platform produces differentiated lignin grades for the same end-applications Futurity targets.

Others

  • LanzaTech: LanzaTech is a US-based clean-tech company using gas-fermentation to convert industrial off-gases into ethanol and chemical building blocks. It is not a direct lignin competitor but is thematically related as a renewable-chemicals platform and has direct governance overlap with Futurity through advisory board member Dr. Sean Simpson.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Futurity Bio-Ventures social profiles

Digital presence

Futurity Bio-Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Futurity Bio-Ventures leadership team

Management profile

Number of profiles

Profiles7 records

Futurity Bio-Ventures funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Futurity Bio-Ventures M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Futurity Bio-Ventures

What does Futurity Bio-Ventures do?

Futurity Bio-Ventures develops and sells a portfolio of lignin-based renewable chemicals and materials derived from New Zealand plantation forestry and pulp/paper by-products. The company's product range includes LIGNO™ lignin grades (LIGNO™ 100, Phenolics, Polyurethanes, UV Additives), LIMA™ asphalt binder additives (including LIMA™ Plus), and METNIN™ SHIELD paper additive, sold to industrial customers in construction, infrastructure, packaging, cosmetics, and textiles as alternatives to fossil-based petrochemicals.

Is Futurity Bio-Ventures a public or private company?

Futurity Bio-Ventures is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Futurity Bio-Ventures founded?

Futurity Bio-Ventures was founded in 2017. It employs 1 to 10 people.

Where is Futurity Bio-Ventures based?

Futurity Bio-Ventures is headquartered in Wainui, New Zealand, in the Oceania region.

How does Futurity Bio-Ventures make money?

Two revenue lines are on record. Renewable Chemical Products Sales are the primary driver. The others are technology Licensing.

Who are Futurity Bio-Ventures's main competitors?

Broad incumbents on record are Domtar (BioChoice), Borregaard, Stora Enso, UPM Biochemicals and Suzano. Emerging players are Renmatix, Bloom Biorenewables and Anomera. MetGen Oy is listed as a direct peer. LanzaTech is listed as an others.

Does Futurity Bio-Ventures have an API?

No public API is recorded for Futurity Bio-Ventures.

What industry is Futurity Bio-Ventures in?

Futurity Bio-Ventures's product category is Renewable Chemicals & Bio-based Materials. Its primary akta.pro industry code is IMAMALAB, Biochemicals & Bio-based Platform Chemicals (cellulose sugars, lignin derivatives, organic acids), with a secondary code of IMAMALAE, Lignin-based Materials & Carbon Products (binders, resins, carbon fiber/activated carbon). Its NAICS code is 325194 and its SIC code is 2860.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales